Fouse Jacqualyn A
- SEC CIK
- 0001405288
No open-market purchases or sales filed in the past year.
Current role at each company
- AGIO Agios Pharmaceuticals, Inc.Directoras of Jun 23, 2026
- MDGL Madrigal Pharmaceuticals, Inc.Directoras of Jun 18, 2026
- INCY Incyte CorpDirectoras of Jun 10, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Fouse Jacqualyn A as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
AGIO Agios Pharmaceuticals, Inc.
Director5 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Apr 10, 2025 (view filing) | Apr 10 | Same day | Fouse Jacqualyn ADirector | SSale | −7.50K | $25.90 | −$194.2K | −4.8%149.2K after | 10b5-1 |
| Apr 10, 2024 (view filing) | Apr 10 | Same day | Fouse Jacqualyn ADirector | SSale | −7.79K | $27.55 | −$214.6K | −5.4%137.4K after | 10b5-1 |
| Jan 24, 2024 (view filing) | Jan 24 | Same day | Fouse Jacqualyn ADirector | SSale | −10.7K | $21.64 | −$232.0K | −7.7%129.3K after | 10b5-1 |
| Jan 9, 2024 (view filing) | Jan 9 | Same day | Fouse Jacqualyn ADirector | SSale | −8.39K | $22.99 | −$192.9K | −6.7%116.1K after | 10b5-1 |
| Jun 30, 2023 (view filing) | Jun 30 | Same day | Fouse Jacqualyn ADirector | SSale | −10.7K | $28.36 | −$304.0K | −9.1%107.0K after | 10b5-1 |